Who invested in leon nanodrugs

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$20Mraised across 2 rounds since 2015, from 2 sources

Latest round: VentureAug 2024
Biggest round: $20MSeries A · Jul 2015
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152017201920212023

$20MSeries A?Venture

First round: Series A, $20M
Biggest round: $20M
Between rounds: 9 years

The rounds

Aug 2024
VentureAmount undisclosed
No investor was named in the report.
Source recorded
Jul 2015
Series A$20M5 new
- TVM Capital
- Signet Healthcare Partners
- CD-Venture
- LifeCare Partners
- Albany Private Equity Holding
From a historical funding record

Founders and team

From leon nanodrugs's own website: 10 on the team.

Christian NafeChief Financial Officer & Managing Director
Dr. Blerina ShkodraChief Scientific Officer
Dr. Matthias SchumacherChief Technology Officer
Dirk WilkenBoard Member
Dr. Frank MuehlenbeckChairman of the board
Dr. Gerhard RiesBoard Member
Dr. Jonathan ReisBoard Member
Dr. Tom HaverkampBoard Member
Maja KuharDirector Marketing
Martin Josef ErhardBusiness Development Director

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2015Venture2024

TVM Capital

Signet Healthcare PartnersCD-VentureLifeCare PartnersAlbany Private Equity Holding

Everyone who backed them

TVM CapitalPrivate equity1round

Signet Healthcare PartnersVC firm1round

CD-VentureVC firm1round

LifeCare PartnersVC firm1round

Albany Private Equity Holdingno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists leon nanodrugs as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.